Pfizer (PFE) has reportedly decided to sell its entire remaining stake in BioNTech (BNTX), showing a lack of confidence in ...

BMY shares drop after halting the Librexia ACS trial, though other milvexian studies continue with top-line data expected in ...

Five years after their celebrated collaboration on a COVID-19 vaccine, Pfizer has initiated a significant divestment, selling ...

BioNTech (NasdaqGS:BNTX) shares caught investors’ attention after Pfizer revealed plans to sell its remaining stake in the company through an overnight block trade. This announcement prompted a wave ...

In the current session, Nutanix Inc. (NASDAQ: NTNX) is trading at $67.25, after a 0.68% drop. Over the past month, the stock ...

BioNTech (BNTX) stock slips as Pfizer (PFE) plans to sell its remaining stake in the COVID-19 vaccine developer in a ...

[NEW YORK] Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech, a remnant from one of the ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...

Investor attention is focused on German vaccine developer BioNTech today as the company hosts its Innovation Day in New York. This event marks a strategic pi ...

Fintel reports that on November 10, 2025, HC Wainwright & Co. maintained coverage of BioNTech SE - Depositary Receipt ...